MX358507B - Antigenos vacunales quimericos contra el virus de la hepatitis c. - Google Patents

Antigenos vacunales quimericos contra el virus de la hepatitis c.

Info

Publication number
MX358507B
MX358507B MX2015005651A MX2015005651A MX358507B MX 358507 B MX358507 B MX 358507B MX 2015005651 A MX2015005651 A MX 2015005651A MX 2015005651 A MX2015005651 A MX 2015005651A MX 358507 B MX358507 B MX 358507B
Authority
MX
Mexico
Prior art keywords
virus
antigens
chimeric
against hepatitis
vaccine antigens
Prior art date
Application number
MX2015005651A
Other languages
English (en)
Spanish (es)
Other versions
MX2015005651A (es
Inventor
Carrera Santiago Dueñas
Blanco Sonia Gonzalez
Noriega Daylen Aguilar
Cañizares Yalena Amador
Ponce De León Liz Alvarez-Lajonchere
Donato Gillian Martínez
Original Assignee
Ct Ingenieria Genetica Biotecnologia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotecnologia filed Critical Ct Ingenieria Genetica Biotecnologia
Publication of MX2015005651A publication Critical patent/MX2015005651A/es
Publication of MX358507B publication Critical patent/MX358507B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24271—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MX2015005651A 2012-11-05 2013-10-28 Antigenos vacunales quimericos contra el virus de la hepatitis c. MX358507B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20120153A CU24112B1 (es) 2012-11-05 2012-11-05 Antígenos vacunales quiméricos contra el virus de la hepatitis c
PCT/CU2013/000006 WO2014067498A1 (es) 2012-11-05 2013-10-28 Antígenos vacunales quiméricos contra el virus de la hepatitis c

Publications (2)

Publication Number Publication Date
MX2015005651A MX2015005651A (es) 2015-08-20
MX358507B true MX358507B (es) 2018-08-22

Family

ID=49724426

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015005651A MX358507B (es) 2012-11-05 2013-10-28 Antigenos vacunales quimericos contra el virus de la hepatitis c.

Country Status (15)

Country Link
US (1) US9676825B2 (enExample)
EP (1) EP2915544B1 (enExample)
JP (1) JP6259831B2 (enExample)
KR (1) KR102093495B1 (enExample)
CN (1) CN104837498B (enExample)
AR (1) AR093341A1 (enExample)
AU (1) AU2013339846B2 (enExample)
CA (1) CA2901346C (enExample)
CU (1) CU24112B1 (enExample)
ES (1) ES2644801T3 (enExample)
IN (1) IN2015DN03925A (enExample)
MX (1) MX358507B (enExample)
RU (1) RU2639504C2 (enExample)
WO (1) WO2014067498A1 (enExample)
ZA (1) ZA201503036B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3319997B1 (en) 2015-07-07 2025-05-07 The Governors of the University of Alberta Hepatitis c virus immunogenic compositions and methods of use thereof
NZ751943A (en) * 2016-09-21 2025-08-29 Univ Alberta Hepatitis c virus immunogenic compositions and methods of use thereof
WO2018200892A1 (en) * 2017-04-27 2018-11-01 The Trustees Of The University Of Pennsylvania NUCLEOSIDE-MODIFIED mRNA-LIPID NANOPARTICLE LINEAGE VACCINE FOR HEPATITIS C VIRUS
CN112601548A (zh) * 2018-03-16 2021-04-02 艾伯塔大学理事会 丙型肝炎病毒肽组合物及其使用方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1047892B (en) * 1999-11-19 2009-01-09 Csl Limited HCV vaccine ingredients
US6544780B1 (en) * 2000-06-02 2003-04-08 Genphar, Inc. Adenovirus vector with multiple expression cassettes
CU23496A1 (es) * 2004-09-03 2010-02-23 Ct Ingenieria Genetica Biotech Composición vacunal contra el virus de la hepatitis c
EP1981537B1 (en) * 2006-01-04 2015-08-26 GlaxoSmithKline Biologicals S.A. HCV E1E2 MF59-adjuvanted protein plus HCV E1E2 encoding alphavirus vector for eliciting HCV-specific T cells.
US7256008B2 (en) 2006-01-06 2007-08-14 Abbott Laboratories Determination of concentration of FK778 by competitive immunoassay
WO2009056535A2 (en) * 2007-10-29 2009-05-07 Genimmune N.V. Methods and kits for inducing a ctl response using a prime boost regimen
US8604179B2 (en) * 2008-04-25 2013-12-10 Toray Industries, Inc. Nucleic acid comprising chimeric gene derived from hepatitis C virus
US8728489B2 (en) * 2008-09-19 2014-05-20 Globeimmune, Inc. Immunotherapy for chronic hepatitis C virus infection
US20110311550A1 (en) * 2008-10-24 2011-12-22 The Scripps Research Institute Agents for hcv treatment

Also Published As

Publication number Publication date
KR102093495B1 (ko) 2020-03-26
CA2901346A1 (en) 2014-05-08
CN104837498A (zh) 2015-08-12
AR093341A1 (es) 2015-06-03
IN2015DN03925A (enExample) 2015-10-02
EP2915544A1 (en) 2015-09-09
ES2644801T3 (es) 2017-11-30
EP2915544B1 (en) 2017-08-09
CU24112B1 (es) 2015-08-27
US9676825B2 (en) 2017-06-13
KR20150079694A (ko) 2015-07-08
CU20120153A7 (es) 2014-06-27
JP2015536936A (ja) 2015-12-24
AU2013339846B2 (en) 2017-08-17
ZA201503036B (en) 2016-01-27
MX2015005651A (es) 2015-08-20
CN104837498B (zh) 2018-05-18
JP6259831B2 (ja) 2018-01-10
WO2014067498A1 (es) 2014-05-08
AU2013339846A1 (en) 2015-05-14
RU2639504C2 (ru) 2017-12-21
CA2901346C (en) 2019-04-23
US20150307558A1 (en) 2015-10-29
RU2015121429A (ru) 2016-12-27

Similar Documents

Publication Publication Date Title
IN2014DN10288A (enExample)
PH12017500727A1 (en) Modified virus-like particles of cmv
MX2012009581A (es) Vacunas para su uso en la profilaxis y tratamiento de la enfermedad del virus de influenza.
MX2021006931A (es) Antigenos del virus de la inmunodeficiencia humana, vectores, composiciones y metodos de uso de estos.
PH12013501683A1 (en) Yeast-based therapeutic for chronic hepatitis b infection
MX2021001053A (es) Vacunas contra virus de la influenza y sus usos.
IN2014KN03063A (enExample)
MX384422B (es) Vector que expresa conjuntamente vacunas y moléculas coestimuladoras
MX364689B (es) Vacuna peptidica para prevencion e inmunoterapia de la demencia tipo alzheimer.
MX2015008847A (es) Composiciones inmunogenicas de virus de influenza y usos de las mismas.
WO2014113490A3 (en) Immunogenic wt-1 peptides and methods of use thereof
MX2013002173A (es) Formas farmaceuticas dirigidas de epitopos multiples para la induccion de una respuesta inmunologica frente a antigenos.
MX346475B (es) Peptidos inmunogenicos monomericos y multimericos.
PH12015500499A1 (en) Recombinant measles virus expressing chikungunya virus polypeptides and their applications
NZ702146A (en) Peptides derived from viral proteins for use as immunogens and dosage reactants
WO2014160747A3 (en) Compositions and methods for the treatment or prevention of human immunodeficiency virus infection
WO2016116905A9 (en) Cmv antigens and uses thereof
MX358507B (es) Antigenos vacunales quimericos contra el virus de la hepatitis c.
NZ751943A (en) Hepatitis c virus immunogenic compositions and methods of use thereof
MX2019007924A (es) Vacunas contra la influenza.
IN2014DN09445A (enExample)
PH12017500817A1 (en) Long acting pharmaceutical compositions for hepatitis c
WO2016012406A3 (en) Attenuated strain of prrs and potential use in immunising preparations
WO2016141201A3 (en) Rational vaccine design for hepatitis c virus
MX2016009952A (es) Proteinas y antigenos del virus de diarrea epidemica porcino (pedv).

Legal Events

Date Code Title Description
FG Grant or registration